New Research on Alzheimer's Disease
Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's Disease (AD), which involves the parts of the brain that control memory, thought and language. Age is the most important known risk factor for AD. The number of people with the disease doubles every 5 years beyond age 65. AD is a slow disease, starting with mild memory loss and ending with severe brain damage. The course the disease takes and how fast changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. Current research is aimed at understanding why AD occurs and who is at greatest risk for developing it, improving the accuracy of diagnosis and ability to identify who is at risk, developing, discovering and testing new treatments for behavioural problems in patients with AD. This book gathers state-of-the-art research from leading scientists throughout the world which offers important information on understanding the underlying causes and discovering the most effective treatments for Alzheimer's Disease.
What people are saying - Write a review
We haven't found any reviews in the usual places.
The Role of Phospholipase A₂ in Alzheimers Disease
Low Molecular Weight Glycosaminoglycans and Apoptosis Potential Treatment of Neurodegenerative Disorders Including Alzheimers Disease
Low Density Lipoprotein ReceptorRelated Protein 1 LRP1 One of the Hallmarks of Alzheimers Disease and Other Complex Degenerative Processes
The Role of Peroxisome ProliferatorActivated Receptors in Alzheimers Disease
3-amyloid peptide agonists Alzheimer disease Alzheimer's disease amyloid beta amyloid precursor protein antioxidant apolipoprotein apoptosis astrocytes beta-amyloid Biochem Biol Chem blood-brain barrier brain ischemia Brain Res cell death cellular ceramide cerebral cholesterol cholinergic cognitive controls cortex cytokines damage Decreased deposition diabetes disorders effects enzyme expression fatty acids free radicals function Gattaz gene growth factor Hipp hippocampus immuno impairment increased induced inflammatory infusion inhibition inhibitors inhibitory avoidance injection injury insulin intracellular ischemia-reperfusion ischemic levels ligands lipid peroxidation lipoprotein receptor-related protein LRP1 markers mediated membrane memory metabolism mice microglia mRNA neurite Neurobiol Aging Neurochem neurodegenerative neuronal neuronal cells neuronal death neurotoxicity NSAIDs oxidative stress pathology pathway patients peptide peroxisome proliferator-activated receptor Pharmacol phospholipase A2 physiological PLA2 activity plaques plasma Pluta PPARG PPARs PPARY presenilin processes rat brain Right ventricle role specific sphingomyelin studies tau protein tissue toxicity transgenic treatment vascular dementia Vehicle Right vivo